REESE DAVID M (EVP, Research and Development) reported 1 transaction at AMGEN INC
Review the transaction codes below to understand the nature of each event.
Filed: 3/18/2026ACC: 0000318154-26-000032
Officer· EVP, Research and Development
Since Jul 2018
-6.02K
Net shares
Net seller
$2.21M
Total sold
0
Open market trades
0B · 0S
1
Total transactions
6.02K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−6.02K
Price / share
$366.21
Trade value
$2.21M
% of position
12.6%
3/16/2026
47.81K→41.79K
Total
Net shares
−6.02K
Net value
-$2.21M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 3/16/2026 | F · Tax Withholding | −6.02K | $366.21 | $2.21M | 12.6% | 47.81K | 41.79K |
| Total | −6.02K | -$2.21M | ||||||
Derivative Transactions0
No derivative transactions reported